Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Abroad (travel likely)RecruitingPHASE3

Conditions

Non-Muscle Invasive Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Liushan Qu) · sysyxllwyh@163.com · 020-81332587
Contact: Principal Investigator (Jian Huang, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Non-muscle Invasive Bladder Cancer

IsraelRecruitingPHASE1

Birmingham, United States · Birmingham, United States

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Abroad (travel likely)RecruitingPHASE3

Tucson, United States · Little Rock, United States

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer · Non-Muscle Invasive Bladder Carcinoma · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Abroad (travel likely)RecruitingPHASE3

Queen Creek, United States · Little Rock, United States

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Bladder Cancer

Abroad (travel likely)RecruitingPHASE3

Washington D.C., United States · Baltimore, United States